Mercia invests £3m to develop testosterone patch for post-menopausal women
A University of Warwick spin-out has raised almost £3m from Mercia Asset Management to develop the world’s first testosterone patch for women with menopausal symptoms. Medherant aims to begin clinical trials later this year and ultimately to gain regulatory approval in the UK and internationally. If successful, it would be the only testosterone replacement patch